Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.8 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
25
Modified dose descriptor starting point:
NOAEC
Value:
44 mg/m³
Explanation for the modification of the dose descriptor starting point:
Corrected inhalatory NOAEC from oral NOAEL: Oral NOAEL x (1/sRVrat) x (ABSoral-rat/ABSinh-human) x (sRVhuman/wRV) Assume ABSoral-rat/ABSinh-human is 50/100 = 0.5 based on phys-chem properties and Endpoint Specific Guidance chapters 8 and 7c (R.7.12) Corrected NOAEC = 50 mg/kg/day x (1/0.38 m3/kg/day) x (0.5) x 6.7 m3/10m3 = 44 mg/m3. Applying the remaining assessment factors of 25, the long-term systemic inhalation DNEL = 1.8 mg/m3.
AF for dose response relationship:
1
Justification:
REACH Guidance
AF for differences in duration of exposure:
2
Justification:
REACH Guidance
Justification:
REACH Guidance not applicable when setting an inhalatin DNEL
AF for other interspecies differences:
2.5
Justification:
REACH Guidance
AF for intraspecies differences:
5
Justification:
REACH Guidance
AF for the quality of the whole database:
1
Justification:
REACH Guidance
AF for remaining uncertainties:
1
Justification:
REACH Guidance
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
2.5 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
100
Modified dose descriptor starting point:
NOAEL
Value:
250 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
Dermal absorption was estimated to be 20% of oral.
AF for dose response relationship:
1
Justification:
Based on REACH Guidance
AF for differences in duration of exposure:
2
Justification:
Based on REACH Guidance
AF for interspecies differences (allometric scaling):
4
Justification:
Based on REACH Guidance
AF for other interspecies differences:
2.5
Justification:
Based on REACH Guidance
AF for intraspecies differences:
5
Justification:
Based on REACH Guidance
AF for the quality of the whole database:
1
Justification:
Based on REACH Guidance
AF for remaining uncertainties:
1
Justification:
Based on REACH Guidance
Acute/short term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
low hazard (no threshold derived)

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

MW

Water Solubility

Log P

Vapor Pressure

Surface Tension

Systemic Toxicity

264

13.1 mg/L

(slightly soluble)

4.84

4.1 Pa (0.0041 KPa)

Log10 Koc 3.16

Yes 90-day oral

DNEL Discussion

1,2,4,5,7,8-Hexoxonane, 3,6,9-triethyl-3,6,9-trimethyl- CAS# 24748-23-0 is a cyclic peroxy ketone

Study: 90-day repeat dose oral

NOAEL: 50 mg/kg/day

Summary: Findings at 50 mg/kg/day were of a minimal nature and did not indicate an adverse effect on

functional integrity. Based on the findings in the liver, kidneys and blood at 150 and 450

mg/kg/day,a No Observed Adverse Effect Level (NOAEL) of 50 mg/kg/day

was established.

 

Worker Inhalation Systemic DNEL

Corrected inhalatory NOAEC from oral NOAEL

 

Oral NOAEL x (1/sRVrat) x (ABSoral-rat/ABSinh-human) x (sRVhuman/wRV)

 

Assume ABSoral-rat/ABSinh-human is 50/100 = 0.5 based on phys-chem properties and Endpoint Specific Guidance chapters 8 and 7c (R.7.12)

 

Corrected NOAEC = 50 mg/kg/day x (1/0.38 m3/kg/day) x (0.5) x 6.7 m3/10m3

= 44 mg/m3

 

Applying remaining assessment factors in accordance with Endpoint Specific Guidance Chapter 8:

 

Correction for interspecies differences: 2.5

44 mg/m3/2.5 = 17.6 mg/m3

Correction for intraspecies differences: 5

17.6 mg/m3/5 = 3.52 mg/m3

Correction for duration between subchronic to chronic: 2

3.53 mg/m3/2 = 1.76 mg/m3

Correction for dose-response: 1

1.76 mg/m3/1 = 1.76 mg/m3

Correction for whole database: 1 due to quality of study

1.76 mg/m3/1 = 1.76 mg/m3

Total AF = 25

1.8 mg/m3DNEL inhalation-systemic-worker

Worker Dermal Systemic DNEL

Oral absorption rat – oral/dermal absorption human: Assume 20% absorption based on the phys-chem data in accordance with Endpoint Specific Guidance Chapter 8 and 7c (R.7.12).

 

50 mg/kg/day/0.2 = 250 mg/kg/day = dermal dose descriptor

 

Applying assessment factors in accordance with Endpoint Specific Guidance Chapter 8:

 

Correction for interspecies differences (apply factor for allometric scaling 4 for rat x 2.5 for additional factors): 10

250 mg/kg/day/10 = 25 mg/kg/day

Correction for intraspecies difference: 5

25 mg/kg/day/5 = 5 mg/kg/day

Correction for duration between sub-chronic to chronic: 2

5 mg/kg/day/2 = 2.5 mg/kg/day

Correction for dose-response: 1 due to NOAEL

2.5mg/kg/day/1 = 2.5

Correction for whole database: 1 due to quality of study

2.5 mg/kg/day/1 = 2.5 mg/kg/day

Total AF = 100

2.5 mg/kg/day DNEL dermal-worker-systemic

 

 

 

 

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
hazard unknown but no further hazard information necessary as no exposure expected

Additional information - General Population